News

The American Academy of Ophthalmology has alerted its members that pink eye (conjunctivitis) may be an early symptom of the coronavirus. On its website, the academy says the current pandemic “increases the likelihood ophthalmologists may be the first providers to evaluate... Read More »

(Editor’s note: Hydroxychloroquine, known by the brand name Plaquenil, is a drug familiar to many Lyme patients.) The University of Minnesota is launching a clinical trial on a post-exposure treatment for the coronavirus disease, COVID-19. This trial is testing... Read More »

Message from Medicare Medicare has temporarily expanded its coverage of telehealth services in response to COVID-19. Medicare beneficiaries can temporarily use telehealth services for common office visits, mental health counseling and preventive health screenings. This will help... Read More »

By Tracie White, Stanford University For decades, the routine treatment for Lyme disease has been standard antibiotics, which usually kill off the infection. But for up to 20% of people with the tick-borne illness, the antibiotics don’t work. Lingering symptoms of muscle pain,... Read More »

Dr. Steven Bock, a Lyme-treating physician, provides information about the coronavirus–and the risk it poses for people with Lyme disease. He explains about the immune system and ways that Lyme patients (and others with compromised immune systems) can protect themselves. Read More »

The federal Tick-Borne Disease Working Group held two days of meetings in Philadelphia on March 3 and 4. Panel members went through the recommendations of the eight subcommittees, accepting some and rejecting others. For the first time, the events were streamed via YouTube. Thus,... Read More »

The federal Tick-Borne Disease Working Group met in Philadelphia on March 3 and 4. Lonnie Marcum, of LymeDisease.org, live-tweeted the proceedings. Click here to read her tweets from Day One. Click below to read her tweets from Day Two. Read More »

The federal Tick-Borne Disease Working Group met in Philadelphia on March 3 and 4. LymeDisease.org’s Lonnie Marcum live-tweeted the proceedings. Click below to see her tweets for the first day. Click here to see tweets for the second day. Read More »

The Spring 2020 issue of the Lyme Times features four articles about disulfiram. The drug has been around for 70 years, but has only recently been used for Lyme disease. Many patients and their doctors report success–but also urge caution. Other topics covered in this... Read More »